OIP5 and breast carcinoma: lncRNA OIP5-AS1 promotes breast cancer progression by regulating miR-216a-5p/GLO1 [27].CLIC2 is a useful biomarker for identifying breast cancer patients who could benefit from immune checkpoint blockade [28].